Business Description
Resverlogix Corp
NAICS : 325414
SIC : 3741
ISIN : CA76128M1086
Description
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -10.7 | |||||
| Debt-to-Equity | -0.11 | |||||
| Debt-to-EBITDA | -1.1 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 29.8 | |||||
| 3-Year FCF Growth Rate | 49 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.74 | |||||
| 9-Day RSI | 44.47 | |||||
| 14-Day RSI | 46.35 | |||||
| 6-1 Month Momentum % | 4.29 | |||||
| 12-1 Month Momentum % | -14.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | -9.68 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -151.63 | |||||
| ROIC % | -50.02 | |||||
| ROC (Joel Greenblatt) % | -6373.48 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.54 | |||||
| EV-to-EBITDA | -2.67 | |||||
| EV-to-FCF | -5.33 | |||||
| Earnings Yield (Greenblatt) % | -39.32 | |||||
| FCF Yield % | -32.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Resverlogix Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.043 | ||
| Beta | 1.42 | ||
| Volatility % | 104.81 | ||
| 14-Day RSI | 46.35 | ||
| 14-Day ATR (€) | 0.002834 | ||
| 20-Day SMA (€) | 0.03525 | ||
| 12-1 Month Momentum % | -14.12 | ||
| 52-Week Range (€) | 0.024 - 0.0555 | ||
| Shares Outstanding (Mil) | 280.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Resverlogix Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Resverlogix Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Resverlogix Corp Frequently Asked Questions
What is Resverlogix Corp(STU:RFS)'s stock price today?
The current price of STU:RFS is €0.03. The 52 week high of STU:RFS is €0.06 and 52 week low is €0.02.
When is next earnings date of Resverlogix Corp(STU:RFS)?
The next earnings date of Resverlogix Corp(STU:RFS) is 2025-02-12 Est..
Does Resverlogix Corp(STU:RFS) pay dividends? If so, how much?
Resverlogix Corp(STU:RFS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers